Three different types of confined placental mosaicism: I, trisomic cytotrophoblast and diploid chorionic stroma; II, diploid cytotrophoblast and trisomic chorionic stroma; III, trisomic cytotrophoblast and chorionic stroma. In all three types the mosaicism is confined to the placenta and the fetus is either non-mosaic diploid (in most cases) or non-mosaic aneuploid (in which case the cytotrophoblast is diploid).
Types of CPM There are three types of CPM, categorised according to the placental cell lineage exhibiting the abnormal cell line (fig 1, table 1 ). Placental mosaicism can be confined to either cytotrophoblast (type I), chorionic stroma (type II), or both cell lineages (type III). CPM is the result of viable postzygotic mitotic mutation(s) occurring in either the progenitor cells of specific placental cell lineages or the true embryoblasts. It can arise in both a diploid conception (mitotic CPM) or in a viable dividing chromosomally abnormal zygote (meiotic CPM). A diploid non-mosaic fetus with chromosomal trisomy confined to both cell lineages of the placenta (type III CPM) implies that the conceptus was originally trisomic (meiotic CPM). At present there is no nomenclature designated for various types of CPM and therefore we propose to label CPM1 6 as a confined placental mosaicism involving chromosome 16 without specification of its type.
Developmental aspects of CPM The existence of a discrepancy between the chromosomal constitution of chorionic tissue and embryonic/fetal tissues is the result of complex developmental events during early embryogenesis. Both the cell lineage involvement and the timing of the occurrence of the second viable cell line are equally important in the final cell distribution.
It has been shown in rodents that, between the eight cell stage and the blastocyst, the cells situated in the innermost layers contribute more frequently to the inner cell mass formation than do the peripheral cells. 6 The elegant experiments with manufactured hexaparental mice performed by Markert and Petters7 have shown that the wall of the blastocyst gives rise exclusively to the chorion and that the complete embryo is derived from only three cells of the inner cell mass. The remaining cells of the inner cell mass contribute to the development '5 The effects of CPM on development may vary with the timing of the chromosome involved, the type of chromosome abnormality, the proportions of the different chromosome complements present, and the tissues affected. For example, CPM type I is frequent (table 1) and appears to be associated with spontaneous abortion and IUGR." CPM type II is also frequent but its effect on fetal development remains unknown."6
The outcome appears to depend also on the nature of the chromosome abnormality as well as the number and the viability ofplacental cells with an abnormal chromosomal complement. Trisomy 16 is the most common aneuploidy observed in CPM. '7 Other frequently reported aneuploidies include trisomies 2, 7, 9, 15, and 22. Interestingly enough, there is a good correlation for some chromosomes involved in chromosomally abnormal spontaneous abortions and those involved in CPM. This suggests that for some chromosomes CPM is mostly the meiotic type whereas for other chromosomes it is the mitotic type. CPM involving monosomy, except for sex chromosome monosomy, does not occur as frequently, presumably because chromosome loss is likely to result in a viable placental cell progeny but other factors might be involved.
In addition to the previous considerations, the low predictive value of CPM is also explained by data shown in table 3. Overall, CPM is confirmed at term in the majority of originally diagnosed pregnancies in CVS. Among individual chromosomes there is heterogeneity, however, with chromosome 9 and 16 having the strongest tendency to persist to term in a form of trisomy/diploidy mosaic. Since not all prenatally diagnosed CPM persists to term, correlation of pregnancy outcome with CVS diagnosis is limited. An accurate interpretation of the effect of CPM is only possible when the term placenta is analysed extensively and the pregnancy course and outcome is correlated with the extent of aneuploid involvement in the term placenta. '8 As illustrated in this figure, the outcome of the postzygotic loss of the extra chromosome is mainly dependent upon the cell lineage involved, but it is also influenced by the timing of the correction and the nature and type of chromosome involved.
When the trisomic chromosome is lost in the trophoblast progenitors (epithelial lining of the placenta), a viable non-mosaic trisomic infant is delivered (fig 2A) . For example, mosaicism involving diploidy in the cytotrophoblast appears to be required for the rescue of trisomy 13 and 18 conceptions.'9 If the correction of aneuploidy involves the loss of the extra chromosome in the embryo blast lineage, a diploid non mosaic fetus/newborn develops, supported by a trisomic placenta ( fig 2B) .
Uniparental disomy
Depending on the parental origin of the lost chromosome, the two remaining chromosomes in the fetus may be of both maternal and paternal origin (biparental disomy, BPD) or may be of only one parental origin (uniparental disomy, UPD), as shown in fig 3. The concept of UPD was first introduced and later excellently reviewed by Engel.'0 If two different homologous chromosomes derive directly from one parent, the term heterodisomy is used; if both homologues are identified and derived from one parent, isodisomy is used. On average, one third of the aneuploidy correction would be expected to result in fetal uniparental disomy but this might well be chromosome dependent. Using this figure and assuming that all cases of CPM type III result from trisomic zygote rescue, one can estimate that the prevalence of UPD around 9 to 10 weeks of pregnancy in this population of women is about 8/10 000. As mentioned previously, CPM involving monosomy does not occur as frequently. In this instance, however, the correction of the monosomy by postzygotic duplication of the single homologue producing an isodisomy should be considered.
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